Skip to main content
TipRanks
Go Ultimate75% OFF

Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis

0 Followers
IN:SHIVALIK

Shivalik Rasayan Ltd

(NSE:SHIVALIK)

Select Model
Rating:60Neutral
Price Target:INR 298.00â–²(5.11% Upside)
Action:reiterated
Date:09/17/26

The score is capped primarily by weak cash generation (negative operating and free cash flow) despite a solid, low-leverage balance sheet and steady revenue growth. Technicals are a meaningful positive with strong trend and momentum, but valuation is a clear headwind due to the high P/E and very low dividend yield.

Positive Factors
Steady Revenue GrowthConsistent revenue expansion indicates resilient demand for the company’s products and supports a constructive multi-quarter operating outlook. Continued top-line growth can provide the scale needed to absorb costs, fund investment, and strengthen the business even though profitability has been uneven.
Negative Factors
Weak Cash GenerationPersistently negative operating and free cash flow signals pressure in converting reported business activity into usable cash. This can increase reliance on cash reserves or financing to support operations and investment, limiting flexibility and making growth more dependent on improved working-capital discipline.

Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:SHIVALIK-28.66%INDA-2.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 4.54B
Dividend Yield
0.18%
Average Volume (3M)
7,835
Price to Earnings (P/E)
31.3
Beta (1Y)
0.68
Revenue Growth
13.01%
EPS Growth
0.57%
Country
India
Employees
267
Sector
General
Sector Strength
55
Industry
Agricultural Inputs

Shivalik Rasayan Ltd Business Overview & Revenue Model

Company Description

Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticid...

Shivalik Rasayan Ltd Financial Statement Overview

Summary

Steady revenue growth and a conservatively levered balance sheet support the fundamentals, but the profile is materially weakened by consistently negative free cash flow and negative operating cash flow in recent years, alongside thinner margins versus earlier peaks.

Income Statement

66Positive

Balance Sheet

78Positive

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue3.75B3.68B3.12B2.72B2.34B2.07B
Gross Profit1.45B1.00B805.70M1.32B1.20B1.13B
EBITDA463.56M498.42M485.11M368.00M439.95M504.71M
Net Income136.70M121.36M166.96M127.17M212.35M256.06M
Balance Sheet
Total Assets08.19B7.34B6.92B5.78B4.88B
Cash, Cash Equivalents and Short-Term Investments343.68M343.68M279.69M377.38M306.71M707.58M
Total Debt01.14B938.83M859.67M655.12M411.22M
Total Liabilities-5.99B2.20B1.98B1.85B1.59B1.24B
Stockholders Equity5.99B5.99B4.15B3.90B3.10B2.87B
Cash Flow
Free Cash Flow-267.77M-581.61M-294.37M-757.31M-821.81M-138.32M
Operating Cash Flow-168.43M-414.68M-86.05M-80.75M-189.49M111.34M
Investing Cash Flow-157.64M-233.18M-208.31M-743.08M-707.72M-233.56M
Financing Cash Flow514.76M711.84M196.69M894.49M496.34M782.07M

Shivalik Rasayan Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price283.50

Price Trends

50DMA344.01Negative
100DMA301.09Negative
200DMA281.44Positive

Market Momentum

MACD-12.75Positive
RSI34.73Neutral
STOCH14.43Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Negative. The current price of 283.50 is below the 20-day moving average (MA) of 303.20, below the 50-day MA of 344.01, and above the 200-day MA of 281.44, indicating a neutral trend. The MACD of -12.75 indicates Positive momentum. The RSI at 34.73 is Neutral, neither overbought nor oversold. The STOCH value of 14.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SHIVALIK.

Shivalik Rasayan Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:SHIVALIK against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:DICINDIN:DICIND69NeutralINR 4.52B17.74―0.62%17.22%25.44%
IN:PODDARMENTIN:PODDARMENT68NeutralINR 2.60B17.55―1.64%4.50%-17.13%
IN:SRDIN:SRD61NeutralINR 2.94B12.52―0.11%19.82%92.88%
IN:SHIVALIKIN:SHIVALIK60NeutralINR 4.72B31.29―0.18%13.01%0.57%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:MANORGIN:MANORG50NeutralINR 3.61B17.51――34.60%-13.51%
IN:BODALCHEMIN:BODALCHEM47NeutralINR 18.94B12.84――44.89%306.54%

* General Sector Average

Performance Comparison

0%100%200%IN:SHIVALIKIN:BODALCHEMIN:DICINDIN:MANORGIN:PODDARMENTIN:SRDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:SHIVALIK and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:SHIVALIKShivalik Rasayan Ltd283.50-120.05-29.75%
IN:BODALCHEMBodal Chemicals Limited147.6092.39167.34%
IN:DICINDDIC India Limited481.75-20.65-4.11%
IN:MANORGMangalam Organics Ltd418.45-27.40-6.15%
IN:PODDARMENTPoddar Pigments Limited245.00-15.48-5.94%
IN:SRDShankar Lal Rampal Dye-Chem Ltd.44.75-19.33-30.16%

Shivalik Rasayan Ltd Corporate Events

Shivalik Rasayan Publishes EGM Voting Results, Highlights Governance Focus

Aug 22, 2026

Shivalik Rasayan Limited disclosed the voting results of its Extraordinary General Meeting held on August 20, 2026 in Dehradun, in line with SEBI listing requirements. The meeting saw participation from promoters and a sizeable public shareholder gro...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 17, 2026